Hartford president sells 8,895 shares after option exercise
Hartford Insurance Group president Adin M. Tooker reported an exercise-and-sale transaction in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Hartford Insurance Group president Adin M. Tooker reported an exercise-and-sale transaction in company stock. On May 27, 2026, he exercised stock options to acquire 8,895 shares of common stock at $49.01 per share, then sold the same 8,895 shares in an open-market transaction at $135.13 per share.
The filing shows this activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on August 25, 2025. Following these transactions, Tooker continues to hold 38,208.27 shares of common stock directly, along with multiple blocks of vested stock options with exercise prices ranging from $51.87 to $140.54 and expirations between 2028 and 2036.
Insider Trade Summary 10b5-1
Exercise and Sale: 8,895 shares ($766K approx. pre-tax spread)
Exercise and Sale
11 txns
Insider
TOOKER ADIN M
Role
President
Sold
8,895 shs ($1.20M)
Approx. gross sale proceeds
$1.20M
Approx. exercise cost
$436K
Approx. pre-tax spread
$766K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 8,895 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,895 | $49.01 | $436K |
| Sale | Common Stock | 8,895 | $135.13 | $1.20M |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Holdings After Transaction:
Stock Option — 194,813 contracts for 177,021 underlying shares (Direct);
Common Stock — 38,208.27 shares (Direct)
Footnotes (10)
- F1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
- F3. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
- F4. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
- F5. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
- F6. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
- F7. The options became fully exercisable on February 28, 2026, the third anniversary of the grant date.
- F8. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options became exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
- F9. One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
- F10. One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
Key Figures
Shares sold: 8,895 shares
Sale price: $135.13/share
Options exercised: 8,895 shares
+5 more
8 metrics
Shares sold
8,895 shares
Common stock sold in open market on May 27, 2026
Sale price
$135.13/share
Price for 8,895 common shares sold
Options exercised
8,895 shares
Stock options converted to common at $49.01 exercise price
Exercise price
$49.01/share
Stock option exercise into 8,895 common shares
Post-transaction common shares
38,208.27 shares
Direct common stock holdings after sale
Largest remaining option block
28,982 underlying shares
Stock options at $140.54, expiring February 24, 2036
Earliest option expiration
8,307 underlying shares
Stock options at $53.81, expiring February 27, 2028
Net buy/sell shares
-8,895 shares
Net effect of reported buys and sells
Key Terms
Rule 10b5-1, Stock Option, derivative security, open-market sale, +1 more
5 terms
Rule 10b5-1 regulatory
"trading plan previously adopted by Mr. Tooker on August 25, 2025, in accordance with Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Stock Option financial
"security_title": "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Hartford (HIG) president Adin M. Tooker report in this Form 4?
Adin M. Tooker reported an options exercise and matching share sale. He exercised 8,895 stock options at $49.01 per share and sold 8,895 common shares at $135.13 per share on May 27, 2026, in an open-market transaction.
Was the Hartford (HIG) insider trade by Adin M. Tooker pre-planned?
Yes, the filing states the transaction was executed under a Rule 10b5-1 trading plan. The plan was previously adopted by Adin M. Tooker on August 25, 2025, providing that the exercise and sale were scheduled in advance rather than timed discretionarily.
What stock options does Adin M. Tooker still have outstanding at Hartford (HIG)?
The filing lists multiple remaining stock option awards on Hartford common stock. These include grants over 28,982, 25,488, 16,492, 24,301, 24,155, 24,094, 8,307 and 25,202 underlying shares, with exercise prices between $51.87 and $140.54 and expirations from 2028 to 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
